What is PFE's current stock price?

PFE is currently trading at $27.30 with a daily change of +0.52%. Visit StocksRunner for live updates.

What are PFE stock's key strengths?

PFE current strengths include: Investors confidence is positive, Outperform the market, Earnings are forecast to grow, Trading below its fair value, Upgraded on attractively valued. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with PFE stock?

Current risk factors for PFE include: Low. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is PFE's current StocksRunner IQ Score?

PFE current StocksRunner IQ Score is: Strong Buy. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence PFE's StocksRunner IQ Score?

PFE StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

PFE Stock Analysis & IQ Rating | Pfizer

Q: Should I buy PFE stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for PFE aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Strong Buy. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for PFE?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in PFE near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

PFE

Pfizer

$27.30

+$0.14 | +0.52%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$27.94

MKT CAP

$155.24B

52W Low

$20.92

VOL

$40.15M

P/E Ratio

20.13

AVG VOL

$46.83M

RSI

55.68

TREND

Uptrend

PFE Stock IQ

Login to see Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

PFE Target Price

Login to display

Strengths

PFE Rewards

Earnings are forecast to grow

PFE Rewards

Investors confidence is positive

PFE Rewards

Trading below its fair value

PFE Rewards

Upgraded on attractively valued

Risk Analysis

PFE Risk Analysis

High risk of cutting its dividend

PFE Price Performance

$27.73 (-1.55%)

$25.85 (+5.61%)

$24.39 (+11.93%)

$25.22 (+8.25%)

1year

6month

3month

1month

PFE Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

PFE Analysts opinion is negative and it remained unchanged from the past 3 months

PFE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

85%

Consensus Rating

67%

Buy
Opinion

33%

Trend
Score

78%

Potential
Score

PFE Street Sentiment is extremely bullish and have positive views on the near-term outlook

PFE Risk Level

PFE has Low risk level

Low

LOW

HIGH

PFE Performance Sentiment

Sentiments overview associated with events and the stock performance

85%

Positive

46 out of 54
events present

13%

Negative

7 out of 54
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$25.77

Resistance Price

$27.73

Current Price Range

$27.16

$25.77

$27.73

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

38%

Consensus Rating

SELL

3

Buy

5

Hold

0

Sell

Date

Action

Rating

Firm

Feb 03, 2026

Reiterate

Neutral

Goldman Sachs

Jan 16, 2026

Initiate

Neutral

UBS

Jan 12, 2026

Initiate

Neutral

UBS

Dec 30, 2025

Reiterate

Buy

Scotiabank

Dec 22, 2025

Downgrade

Hold

Runners Also Watch

Close Price

Change

NVO

Novo Nordisk A/S

38.83

+0.28%

NVS

Novartis AG

155.80

-0.65%

SNY

Sanofi

43.94

-0.07%

AZN

Astrazeneca

193.31

-0.86%

ABBV

AbbVie

227.68

+0.30%

PFE Latest Analysis +

Pfizer: Cheap For A Reason.

Today

$27.30 | +0.52%

Potential

BridgeBios Rare-Disease Pipeline Sparks Growth Buzz. BridgeBio Pharma Inc. (NASDAQ:BBIO) is drawing renewed investor attention as the biotech company advances a slate of rare-disease therapies toward potential regulatory filings and commercial launches.William Blair initiated coverage on the commercial-stage biotech highlighting the company’.s expanding pipeline of treatments targeting rare genetic conditions.BridgeBio’.s Unique PositionAnalyst John Boyle wrote “.BridgeBio is in a

Tue Mar 10, 2026

$27.16 | +1.31%

Activity

Pfizers Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable?. Key PointsPfizers per-share profit in 2025 declined as the company incurred significant impairment charges.

Mon Mar 9, 2026

$26.81 | -0.89%

Activity

Pfizer reports positive data from a Phase 2 study for the atopic dermatitis antibody.

Mon Mar 9, 2026

$26.81 | -0.89%

Activity

Pfizer: Tilrekimig Antibody Phase 2 Study Meets Primary Goal In Moderate To Severe Atopic Dermatitis . (RTTNews) - Drug major Pfizer Inc. (PFE) Monday announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermatitis. The company noted that phase 3 planning for atopic dermatitis is ongoing with a pi

Mon Mar 9, 2026

$26.81 | -0.89%

Activity

Noteworthy Friday Option Activity: PFE CAPR DIS. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Pfizer Inc (Symbol: PFE) where a total volume of 198935 contracts has been traded thus far today a contract volume which is representative of approximately 19

Fri Mar 6, 2026

$27.05 | +1.73%

Momentum

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It. Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Fri Mar 6, 2026

$27.05 | +1.73%

Activity

China Clears Weight-Loss Shot As Pfizer Enters Crowded Market. China'.s National Medical Products Administration has approved Pfizer Inc.’.s (NYSE:PFE) ecnoglutide injection for chronic weight management in adults with overweight or obesity marking the first approval of a cAMP-biased GLP-1 receptor agonist designed to deliver sustained weight reduction and metabolic benefits.Pfizer’.s CompetitionBloomberg noted that Pfizer is entering a market currently dominated by Novo Nordisk A/

Fri Mar 6, 2026

$27.05 | +1.73%

Activity

Smart Money Is Betting Big In PFE Options. Deep-pocketed investors have adopted a bearish approach towards Pfizer (NYSE:PFE) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in PFE usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga'.s options scanne

Thu Mar 5, 2026

$26.61 | -0.04%

Momentum

Argus Turns ish on Pfizer (PFE) Highlights GLP-1 and Oncology Pipeline. Pfizer Inc. (NYSE:PFE) is included among the 14 Best Dividend Stocks to Invest in Under $50. On March 2 Argus upgraded Pfizer Inc. (NYSE:PFE) to Buy from Hold. The firm set a $35 price target on the stock. Argus said it sees encouraging progress in the companys GLP-1 pipeline along with what it described as [….]

Thu Mar 5, 2026

$26.61 | -0.04%

Potential

FAQ About PFE Stock Insights

What is PFE current stock price?

What are PFE stock strengths?

What is PFE Risk Level?

What is PFE market cap and volume?

What is PFE current Stock IQ?

Should I buy PFE stock right now?

Is PFE a Strong Buy right now?

What does a 'Strong Buy' rating mean for PFE?

What does a 'Strong Sell' rating mean for PFE?

What factors influence PFE's Stock IQ?

Explore our PFE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored PFE Stock Strategies
Effective Risk Management

FIND US ON

Receive our PFE Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

PFE

Pfizer

Set Alerts

Current Price

$27.30

+$0.14 | +0.52%

52W High

$27.94

MKT CAP

$155.24B

52W Low

$20.92

VOL

$40.15M

P/E Ratio

20.13

AVG VOL

$46.83M

RSI

55.68

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

NVO

Novo Nordisk A/S

38.83

+0.28%

NVS

Novartis AG

155.80

-0.65%

SNY

Sanofi

43.94

-0.07%

AZN

Astrazeneca

193.31

-0.86%

ABBV

AbbVie

227.68

+0.30%

PFE Price Performance

$27.73 (-1.55%)

$25.85 (+5.61%)

$24.39 (+11.93%)

$25.22 (+8.25%)

1year

6month

3month

1month

PFE Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

PFE Analysts opinion is negative and it remained unchanged from the past 3 months

PFE Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

85%

Consensus Rating

67%

Buy
Opinion

33%

Trend
Score

78%

Potential
Score

PFE Street Sentiment is extremely bullish and have positive views on the near-term outlook

PFE Risk Level

PFE has Low risk level

Low

LOW

HIGH

PFE Performance Sentiment

Sentiments overview associated with events and the stock performance.

85%

Positive

46 out of 54
events present

13%

Negative

7 out of 54
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$25.77

Resistance Price

$27.73

Current Price Range

$27.16

$25.77

$27.73

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

38%

Consensus Rating

SELL

3

Buy

5

Hold

0

Sell

Date

Action

Rating

Firm

Feb 03, 2026

Reiterate

Neutral

Goldman Sachs

Jan 16, 2026

Initiate

Neutral

UBS

Jan 12, 2026

Initiate

Neutral

UBS

Dec 30, 2025

Reiterate

Buy

Scotiabank

Dec 22, 2025

Downgrade

Hold

PFE Stock IQ

Login to unlock Pfizer (PFE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

PFE Rewards

Earnings are forecast to grow

PFE Rewards

Investors confidence is positive

PFE Rewards

Trading below its fair value

PFE Rewards

Upgraded on attractively valued

Risk Analysis

PFE Risk Analysis

High risk of cutting its dividend

PFE Latest Analysis

Pfizer: Cheap For A Reason.

Today

$27.30 | +0.52%

Potential

BridgeBios Rare-Disease Pipeline Sparks Growth Buzz. BridgeBio Pharma Inc. (NASDAQ:BBIO) is drawing renewed investor attention as the biotech company advances a slate of rare-disease therapies toward potential regulatory filings and commercial launches.William Blair initiated coverage on the commercial-stage biotech highlighting the company’.s expanding pipeline of treatments targeting rare genetic conditions.BridgeBio’.s Unique PositionAnalyst John Boyle wrote “.BridgeBio is in a

Tue Mar 10, 2026

$27.16 | +1.31%

Activity

Pfizers Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable?. Key PointsPfizers per-share profit in 2025 declined as the company incurred significant impairment charges.

Mon Mar 9, 2026

$26.81 | -0.89%

Activity

Pfizer reports positive data from a Phase 2 study for the atopic dermatitis antibody.

Mon Mar 9, 2026

$26.81 | -0.89%

Activity

Pfizer: Tilrekimig Antibody Phase 2 Study Meets Primary Goal In Moderate To Severe Atopic Dermatitis . (RTTNews) - Drug major Pfizer Inc. (PFE) Monday announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermatitis. The company noted that phase 3 planning for atopic dermatitis is ongoing with a pi

Mon Mar 9, 2026

$26.81 | -0.89%

Activity

Noteworthy Friday Option Activity: PFE CAPR DIS. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Pfizer Inc (Symbol: PFE) where a total volume of 198935 contracts has been traded thus far today a contract volume which is representative of approximately 19

Fri Mar 6, 2026

$27.05 | +1.73%

Momentum

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It. Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Fri Mar 6, 2026

$27.05 | +1.73%

Activity

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of PFE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our PFE Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

PFE Stock trends

PFE Stock performance

PFE Stock analysis

PFE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing PFE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing PFE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

PFE Stock Analysis & IQ Rating | Pfizer

PFE Stock IQ

PFE Target Price

PFE Analysts Opinion

PFE Street Sentiment

PFE Risk Level

PFE Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our PFE Stock insights

Receive our PFE Daily Alerts

PFE Street Sentiment

PFE Risk Level

Key Price Levels

Latest Analyst Actions

Discover PFE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of PFE. We're here to help you make informed investment decisions today.

Receive our PFE Daily Alerts

PFE Alerts